Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA

PHASE3CompletedINTERVENTIONAL
Enrollment

484

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

June 30, 2007

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

2-dose oral live attenuated G1P[8] human rotavirus vaccine

Trial Locations (42)

15241

GSK Investigational Site, Pittsburgh

22911

GSK Investigational Site, Charlottesville

27103

GSK Investigational Site, Winston-Salem

28352

GSK Investigational Site, Laurinburg

28607

GSK Investigational Site, Deerfield

28713

GSK Investigational Site, Bryson City

28721

GSK Investigational Site, Clyde

28734

GSK Investigational Site, Franklin

29405

GSK Investigational Site, North Charleston

29407

GSK Investigational Site, Charleston

29412

GSK Investigational Site, Charleston

37620

GSK Investigational Site, Bristol

37660

GSK Investigational Site, Kingsport

44304

GSK Investigational Site, Akron

44505

GSK Investigational Site, Youngstown

44512

GSK Investigational Site, Boardman

44514

GSK Investigational Site, Youngstown

45406

GSK Investigational Site, Dayton

48382

GSK Investigational Site, Commerce Twp

54449

GSK Investigational Site, Marshfield

60115

GSK Investigational Site, DeKalb

66202

GSK Investigational Site, Overland Park

72015

GSK Investigational Site, Benton

72023

GSK Investigational Site, Cabot

72117

GSK Investigational Site, North Little Rock

72205

GSK Investigational Site, Little Rock

72401

GSK Investigational Site, Jonesboro

77074

GSK Investigational Site, Houston

77802

GSK Investigational Site, Bryan

80112

GSK Investigational Site, Englewood

84041

GSK Investigational Site, Layton

84057

GSK Investigational Site, Orem

84088

GSK Investigational Site, West Jordan

84095

GSK Investigational Site, South Jordan

84405

GSK Investigational Site, Ogden

84604

GSK Investigational Site, Provo

90711

GSK Investigational Site, Lakewood

90723

GSK Investigational Site, Paramount

91107

GSK Investigational Site, Pasadena

03756

GSK Investigational Site, Lebanon

02914

GSK Investigational Site, East Providence

02903

GSK Investigational Site, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY